Nature’s Toolbox, Inc., a Rio Rancho, NM-based life science company developing domestically-sourced biomanufacturing solutions for the delivery of personalized therapeutics and biologics, raised $15M in venture debt from J.P. Morgan.
The company intends to use the financing to support the adoption of its distributed biomanufacturing systems and development of end-to-end domestic supply chain for critical biomaterials.
Led by CEO Jamie Coffin, Nature’s Toolbox is helping the healthcare industry with their new biomanufacturing solutions. It is developing innovative systems like NTxpress® and NTxscribe® to enable manufacturing of mRNA vaccines and protein therapeutics in an eco-friendly and sustainable way. These processes enable NTx’s platform to scale from personalized medicine dosage to pandemic volume.
FInSMEs
05/12/2024